Richard Daniell sold $1.9M of TEVA stock

Richard Daniell, EVP, Europe Commercial of Teva Pharmaceutical Industries Ltd (TEVA), sold 45,003 shares of TEVA stock worth $1.9M, per an SEC Form 4 filed Nov 12, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 9, 2026, 3 days before it was made public.

TEVA has moved +1.6% since the trade date, from $42.97 to $43.65 (Nov 12, 2026 close).